Literature DB >> 33717064

Renal Involvement and HBV Infection Are Common in Chinese Patients With Cryoglobulinemia.

Wei Bai1,2, Lixia Zhang3, Jiuliang Zhao1,2, Shangzhu Zhang1,2, Jiaxin Zhou1,2, Xiaomei Leng1,2, Zhengyin Liu4, Wenling Ye5, Bing Han6, Xinping Tian1,2, Mengtao Li1,2, Yan Zhao1,2, Xiaofeng Zeng1,2.   

Abstract

Objectives: This study aimed to describe the main characteristics of Chinese patients with cryoglobulinemia, especially the characteristics of patients with different causes of cryoglobulinemia.
Methods: Eighty inpatients diagnosed with cryoglobulinemia from different wards in Peking Union Medical College Hospital were included in this study. Demographic, clinical, biological, and renal pathological data were collected. We analyzed the characteristics of 61 patients with different causes of cryoglobulinemia.
Results: Most patients (36/80, 45%) were diagnosed between 40 and 60 years of age. The male: female ratio was 1:1.5. Mixed (II + III) cryoglobulinemia accounted for the majority (43.8%) of cases. Renal involvement (87.5%), cutaneous involvement (57.5%), and fever (27.5%) were the most common clinical manifestations, while other manifestations included serositis and pulmonary and gastrointestinal involvement. The most common renal histopathological pattern was membranoproliferative glomerulonephritis (25/42, 59.5%). The secondary causes of cryoglobulinemia included infectious diseases (26/61, 32.5%), such as hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, and connective tissue diseases (22/61, 27.5%), such as lupus and hematologic tumors (13/61, 16.3%). Patients with hematologic tumors were diagnosed at an older age (P = 0.044) and mostly had type I cryoglobulinemia (P < 0.001). No significant difference in clinical or biological manifestations was found among patients with different causes of cryoglobulinemia. Conclusions: This is the largest cohort of Chinese patients with cryoglobulinemia. We found that renal involvement and HBV infection might be more common in Chinese patients with cryoglobulinemia.
Copyright © 2021 Bai, Zhang, Zhao, Zhang, Zhou, Leng, Liu, Ye, Han, Tian, Li, Zhao and Zeng.

Entities:  

Keywords:  HBV infection; autoimmunity diseases; cryoglobulinemia; renal involvement; vasculitis

Year:  2021        PMID: 33717064      PMCID: PMC7947000          DOI: 10.3389/fimmu.2021.580271

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  33 in total

1.  Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Authors:  Benjamin Terrier; Evguenia Krastinova; Isabelle Marie; David Launay; Adeline Lacraz; Pauline Belenotti; Luc de Saint-Martin; Thomas Quemeneur; Antoine Huart; Fabrice Bonnet; Guillaume Le Guenno; Jean-Emmanuel Kahn; Olivier Hinschberger; Patricia Rullier; Elisabeth Diot; Estibaliz Lazaro; Frank Bridoux; Thierry Zénone; Fabrice Carrat; Olivier Hermine; Jean-Marc Léger; Xavier Mariette; Patricia Senet; Emmanuelle Plaisier; Patrice Cacoub
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

2.  The experience of management of chronic hepatitis B in China.

Authors:  H Ren
Journal:  J Viral Hepat       Date:  2017-11       Impact factor: 3.728

3.  Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.

Authors:  David Saadoun; Jérémie Sellam; Pascale Ghillani-Dalbin; Richard Crecel; Jean-Charles Piette; Patrice Cacoub
Journal:  Arch Intern Med       Date:  2006-10-23

Review 4.  Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Authors:  Benjamin Terrier; Isabelle Marie; David Launay; Adeline Lacraz; Pauline Belenotti; Luc de Saint-Martin; Thomas Quemeneur; Antoine Huart; Fabrice Bonnet; Guillaume Le Guenno; Jean-Emmanuel Kahn; Olivier Hinschberger; Patricia Rullier; Elisabeth Diot; Estibaliz Lazaro; Frank Bridoux; Thierry Zénone; Fabrice Carrat; Olivier Hermine; Jean-Marc Léger; Xavier Mariette; Patricia Senet; Emmanuelle Plaisier; Patrice Cacoub
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

5.  Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

Authors:  G Monti; M Galli; F Invernizzi; P Pioltelli; F Saccardo; A Monteverde; M Pietrogrande; P Renoldi; S Bombardieri; G Bordin
Journal:  QJM       Date:  1995-02

Review 6.  Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Authors:  Benjamin Terrier; Isabelle Marie; Adeline Lacraz; Pauline Belenotti; Fabrice Bonnet; Laurent Chiche; Bruno Graffin; Arnaud Hot; Jean-Emmanuel Kahn; Catherine Michel; Thomas Quemeneur; Luc de Saint-Martin; Olivier Hermine; Jean-Marc Léger; Xavier Mariette; Patricia Senet; Emmanuelle Plaisier; Patrice Cacoub
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

7.  Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC).

Authors:  M Galli; G Monti; F Invernizzi; A Monteverde; S Bombardieri; A Gabrielli; S Migliaresi; C Mussini; E Ossi; M Pietrogrande
Journal:  Ann Ital Med Int       Date:  1992 Oct-Dec

Review 8.  Renal involvement in HCV-related vasculitis.

Authors:  Benjamin Terrier; Patrice Cacoub
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-04-03       Impact factor: 2.947

Review 9.  New insights in cryoglobulinemic vasculitis.

Authors:  Filipa Silva; Claudemira Pinto; Arsénio Barbosa; Tiago Borges; Carlos Dias; Jorge Almeida
Journal:  J Autoimmun       Date:  2019-08-02       Impact factor: 7.094

10.  Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.

Authors:  Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Valter Gattei; Michela Ghersetti; Pietro Bulian; Giulia Moratelli; Gabriele Grassi; Francesca Zorat; Gabriele Pozzato
Journal:  Diseases       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.